The understanding of possible fat distribution-mediated effects and the molecular mechanisms that regulate different pathophysiological conditions (i.e., insulin sensitivity, chronic pain, and proinflammatory actions) in lymphedema need to be further investigated. This evidence concerns the gene INS and lymphedema.